Literature DB >> 33547385

A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.

Cynthia Tang1, Jimin Han1, Sonal Dalvi1, Kannan Manian1, Lauren Winschel1, Stefanie Volland2, Celia A Soto1, Chad A Galloway1, Whitney Spencer1, Michael Roll1, Caroline Milliner3, Vera L Bonilha3, Tyler B Johnson4, Lisa Latchney1, Jill M Weimer4, Erika F Augustine5, Jonathan W Mink5, Vamsi K Gullapalli1, Mina Chung1,6, David S Williams2, Ruchira Singh7,8,9.   

Abstract

Mutations in CLN3 lead to photoreceptor cell loss in CLN3 disease, a lysosomal storage disorder characterized by childhood-onset vision loss, neurological impairment, and premature death. However, how CLN3 mutations cause photoreceptor cell death is not known. Here, we show that CLN3 is required for phagocytosis of photoreceptor outer segment (POS) by retinal pigment epithelium (RPE) cells, a cellular process essential for photoreceptor survival. Specifically, a proportion of CLN3 in human, mouse, and iPSC-RPE cells localized to RPE microvilli, the site of POS phagocytosis. Furthermore, patient-derived CLN3 disease iPSC-RPE cells showed decreased RPE microvilli density and reduced POS binding and ingestion. Notably, POS phagocytosis defect in CLN3 disease iPSC-RPE cells could be rescued by wild-type CLN3 gene supplementation. Altogether, these results illustrate a novel role of CLN3 in regulating POS phagocytosis and suggest a contribution of primary RPE dysfunction for photoreceptor cell loss in CLN3 disease that can be targeted by gene therapy.

Entities:  

Year:  2021        PMID: 33547385      PMCID: PMC7864947          DOI: 10.1038/s42003-021-01682-5

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  94 in total

1.  Kinetic studies of rod outer segment binding and ingestion by cultured rat RPE cells.

Authors:  M O Hall; T Abrams
Journal:  Exp Eye Res       Date:  1987-12       Impact factor: 3.467

2.  Neuronal ceroid lipofuscinosis: a common pathway?

Authors:  Dixie-Ann Persaud-Sawin; Talal Mousallem; Christine Wang; Adam Zucker; Eiki Kominami; Rose-Mary N Boustany
Journal:  Pediatr Res       Date:  2007-02       Impact factor: 3.756

3.  Support for a proposed retinoid-processing protein complex in apical retinal pigment epithelium.

Authors:  Vera L Bonilha; Sanjoy K Bhattacharya; Karen A West; John S Crabb; Jian Sun; Mary E Rayborn; Maria Nawrot; John C Saari; John W Crabb
Journal:  Exp Eye Res       Date:  2004-09       Impact factor: 3.467

Review 4.  The genetics of inherited macular dystrophies.

Authors:  M Michaelides; D M Hunt; A T Moore
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

5.  Spectral profiling of autofluorescence associated with lipofuscin, Bruch's Membrane, and sub-RPE deposits in normal and AMD eyes.

Authors:  Alan D Marmorstein; Lihua Y Marmorstein; Hirokazu Sakaguchi; Joe G Hollyfield
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

6.  Ezrin promotes morphogenesis of apical microvilli and basal infoldings in retinal pigment epithelium.

Authors:  V L Bonilha; S C Finnemann; E Rodriguez-Boulan
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

7.  Fundus Autofluorescence and RPE Lipofuscin in Age-Related Macular Degeneration.

Authors:  Janet R Sparrow; Tobias Duncker
Journal:  J Clin Med       Date:  2014       Impact factor: 4.241

8.  Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium.

Authors:  Kimberly A Toops; Li Xuan Tan; Zhichun Jiang; Roxana A Radu; Aparna Lakkaraju
Journal:  Mol Biol Cell       Date:  2014-11-05       Impact factor: 4.138

9.  Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.

Authors:  Tarah Nelson; David A Pearce; Attila D Kovács
Journal:  Biosci Rep       Date:  2017-11-23       Impact factor: 3.840

10.  BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure.

Authors:  Karina E Guziewicz; Artur V Cideciyan; William A Beltran; András M Komáromy; Valerie L Dufour; Malgorzata Swider; Simone Iwabe; Alexander Sumaroka; Brian T Kendrick; Gordon Ruthel; Vince A Chiodo; Elise Héon; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

View more
  7 in total

1.  Heterogeneity of Potassium Channels in Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium.

Authors:  Iina Korkka; Heli Skottman; Soile Nymark
Journal:  Stem Cells Transl Med       Date:  2022-07-20       Impact factor: 7.655

2.  Phenotypic variant of CLN3 mutation.

Authors:  Avinash Honasoge; Bradley T Smith
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-15

3.  Retinal Degeneration and Microglial Dynamics in Mature Progranulin-Deficient Mice.

Authors:  Kei Takahashi; Shinsuke Nakamura; Masamitsu Shimazawa; Hideaki Hara
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 4.  Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses.

Authors:  Ahmed Morsy; Angelica V Carmona; Paul C Trippier
Journal:  Molecules       Date:  2021-10-15       Impact factor: 4.411

Review 5.  Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses.

Authors:  Udo Bartsch; Stephan Storch
Journal:  Front Neurol       Date:  2022-04-18       Impact factor: 4.003

Review 6.  CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.

Authors:  Tirthankar Sen; Rajkumar P Thummer
Journal:  Neurotox Res       Date:  2022-08-31       Impact factor: 3.978

7.  CLN3, at the crossroads of endocytic trafficking.

Authors:  Susan L Cotman; Stéphane Lefrancois
Journal:  Neurosci Lett       Date:  2021-07-16       Impact factor: 3.197

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.